Transmission dynamics and control of Ebola virus disease (EVD): A review

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Chowell, Gerardo ^a,b   Nishiura, Hiroshi ^c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Basic reproduction number; Behavior change; Case fatality ratio; Control interventions; Ebola Virus Disease; Isolation; Serial interval; Transmission model; West Africa,Incubation

Indexed keywords

AFRICA; BASIC REPRODUCTION NUMBER; CASE FATALITY RATE; CLINICAL EFFECTIVENESS; CULTURAL FACTOR; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; EPIDEMIOLOGICAL DATA; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HUMAN; INCUBATION TIME; INFECTION; INFECTION CONTROL; INFECTION SENSITIVITY; MATHEMATICAL MODEL; PUBLIC HEALTH; REVIEW; SERIAL INTERVAL; SOCIAL ASPECT; VIRUS TRANSMISSION; WEST AFRICA; DISEASE OUTBREAKS; HEMORRHAGIC FEVER, EBOLA; THEORETICAL MODEL; TRANSMISSION;

AFRICA, WESTERN; DISEASE OUTBREAKS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MODELS, THEORETICAL;

EID: 84964315701     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-014-0196-0     Document Type: Review

References (100)

1. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keïta S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traoré A, Kolié M, Malano ER, Heleze E, Bocquin A, Mély S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, et al: Emergence of Zaire Ebola Virus Disease in Guinea -preliminary report. N Engl J Med, in press.
2. Gire SK, Goba A, Andersen KG, Sealfon RS, Park DJ, Kanneh L, Jalloh S, Momoh M, Fullah M, Dudas G, Wohl S, Moses LM, Yozwiak NL, Winnicki S, Matranga CB, Malboeuf CM, Qu J, Gladden AD, Schaffner SF, Yang X, Jiang PP, Nekoui M, Colubri A, Coomber MR, Fonnie M, Moigboi A, Gbakie M, Kamara FK, Tucker V, Konuwa E, et al: Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014, 345:1369-1372.
3. World Health Organization: Ebola Virus Disease, West Africa -U pdate on 27 July 2014. 2014.
4. Ebola virus disease update -West Africa, 08 August 2014. 2014.
5. Meltzer MI, Atkins CY, Santibanez S, Knust B, Petersen BW, Ervin ED, Nichol ST, Damon IK, Washington ML: Estimating the future number of cases in the ebola epidemic --liberia and sierra leone, 2014-2015. MMWR Surveill Summ 2014, 63:1-14.
6. WHO Ebola Response Team: Ebola Virus Disease in West Africa -the first 9 months of the epidemic and forward projections. N Engl J Med, in press.
7. Nishiura H, Chowell G: Early transmission dynamics of Ebola virus disease (EVD), West Africa, March to August 2014. Euro Surveill 2014, 19. pii: 20894.
8. Althaus CL: Estimating the reproduction number of Zaire ebolavirus (EBOV) during the 2014 outbreak in West Africa. PLOS Currents Outbreaks 2014.
9. Fisman D, Khoo E, Tuite A: Early epidemic dynamics of the West African 2014 Ebola outbreak: estimates derived with a simple two-parameter model. PLOS Currents Outbreaks 2014.
10. Fauci AS: Ebola -underscoring the global disparities in health care resources. N Engl J Med 2014, 371:1084-1086.
11. Bausch DG, Schwarz L: Outbreak of ebola virus disease in Guinea: where ecology meets economy. PLoS Negl Trop Dis 2014, 8:e3056.
12. What is Contact Tracing? Centers for Disease Control and Prevention. accessed on September 18, 2014.
13. Okeke IN: Divining without Seeds: the Case for Strengthening Laboratory Medicine in Africa. Ithaca: Cornell University Press; 2011:200.
14. Del Rio C, Mehta AK, Lyon Iii GM, Guarner J: Ebola Hemorrhagic Fever in 2014: the tale of an evolving epidemic. Ann Intern Med 2014. doi:10.7326/M14-1880.
15. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Délicat A, Paweska JT, Gonzalez JP, Swanepoel R: Fruit bats as reservoirs of Ebola virus. Nature 2005, 438:575-576.
16. Briand S, Bertherat E, Cox P, Formenty P, Kieny MP, Myhre JK, Roth C, Shindo N, Dye C: The international Ebola emergency. N Engl J Med 2014, 371:1180-1183.
17. House T, Inglis N, Ross JV, Wilson F, Suleman S, Edeghere O, Smith G, Olowokure B, Keeling MJ: Estimation of outbreak severity and transmissibility: Influenza A(H1N1)pdm09 in households. BMC Med 2012, 10:117.
18. Centers for Disease Control and Prevention (CDC): Outbreaks Chronology: Ebola Hemorrhagic Fever.
19. Pigott DM, Golding N, Mylne A, Huang Z, Henry AJ, Weiss DJ, Brady OJ, Kraemer MU, Smith DL, Moyes CL, Bhatt S, Gething PW, Horby PW, Bogoch II, Brownstein JS, Mekaru SR, Tatem AJ, Khan K, Hay SI: Mapping the zoonotic niche of Ebola virus disease in Africa. Elife 2014, 3. doi:10.7554/eLife.04395.
20. The World Health Organization: Ebola Virus Disease.
21. Bwaka MA, Bonnet MJ, Calain P, Colebunders R, De Roo A, Guimard Y, Katwiki KR, Kibadi K, Kipasa MA, Kuvula KJ, Mapanda BB, Massamba M, Mupapa KD, Muyembe-Tamfum JJ, Ndaberey E, Peters CJ, Rollin PE, Van den Enden E, Van den Enden E: Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis 1999, 179:S1-S7.
22. Centers for Disease Control and Prevention: Transmission of Ebola (Ebola Virus Disease). 2014. accessed on September 18, 2014.
23. Weingartl HM, Embury-Hyatt C, Nfon C, Leung A, Smith G, Kobinger G: Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2012, 2:811.
24. Khan AS, Tshioko FK, Heymann DL, Le Guenno B, Nabeth P, Kerstiëns B, Fleerackers Y, Kilmarx PH, Rodier GR, Nkuku O, Rollin PE, Sanchez A, Zaki SR, Swanepoel R, Tomori O, Nichol ST, Peters CJ, Muyembe-Tamfum JJ, Ksiazek TG: The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 1999, 179:S76-S86.
25. Baron RC, McCormick JB, Zubeir OA: Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ 1983, 61:997-1003.
26. Ftika L, Maltezou HC: Viral haemorrhagic fevers in healthcare settings. J Hosp Infect 2013, 83:185-192.
27. Anderson RM, May RM: Infectious Diseases of Humans. Oxford: Oxford University Press; 1991.
28. Diekmann O, Heesterbeek J: Mathematical Epidemiology of Infectious Diseases: Model Building. Analysis and Interpretation: Wiley; 2000.
29. Wallinga J, Teunis P: Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. Am J Epidemiol 2004, 160:509-516.
30. Chowell G, Hengartner NW, Castillo-Chavez C, Fenimore PW, Hyman JM: The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. J Theor Biol 2004, 229:119-126.
31. Legrand J, Grais RF, Boelle PY, Valleron AJ, Flahault A: Understanding the dynamics of Ebola epidemics. Epidemiol Infect 2007, 135:610-621.
32. Chowell G, Hengartner NW, Castillo-Chavez C, Fenimore PW, Hyman JM: The basic reproductive number of Ebola and the effects of public health measures: the cases of Congo and Uganda. J Theor Biol 2004, 229:119-126.
33. Lekone PE, Finkenstadt BF: Statistical inference in a stochastic epidemic SEIR model with control intervention: Ebola as a case study. Biometrics 2006, 62:1170-1177.
34. Francesconi P, Yoti Z, Declich S, Onek PA, Fabiani M, Olango J, Andraghetti R, Rollin PE, Opira C, Greco D, Salmaso S: Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerg Infect Dis 2003, 9:1430-1437.
35. Gomes MF, Piontti AP, Rossi L, Chao D, Longini I, Halloran ME, Vespignani A: Assessing the international spreading risk associated with the 2014 West African Ebola outbreak. PLOS Currents Outbreaks 2014. Edition 1. doi:10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5.
36. Towers S, Patterson-Lomba O, Castillo-Chavez C: Temporal variations in the effective reproduction number of the 2014 West Africa Ebola outbreak. PLOS Currents Outbreaks 2014. Edition 1. doi:10.1371/currents. outbreaks.9e4c4294ec8ce1adad283172b16bc908
37. Plachouras D, Sudre B, Testa M, Robesyn E, Coulombier D: Letter to the editor: Early transmission dynamics of Ebola virus disease (EVD), West Africa, March to August 2014. Euro Surveill 2014, 19. pii: 20907.
38. Nishiura H, Chowell G: Authors' reply: Feedback from modelling to surveillance of Ebola virus disease. Euro Surveill 2014, 19. pii: 20908.
39. Bettencourt LM: An ensemble trajectory method for real-time modeling and prediction of unfolding epidemics: analysis of the 2005 Marburg Fever outbreak in Angola. In Mathematical and Statistical Estimation Approaches. Edited by Chowell G, Hyman JM, Bettencourt LM, Castillo-Chavez C. The Netherlands: Springer; 2009.
40. Ajelli M, Merler S: Transmission potential and design of adequate control measures for Marburg hemorrhagic fever. PLoS One 2012, 7:e50948.
41. Chowell G, Shim E, Brauer F, Diaz-Duenas P, Hyman JM, Castillo-Chavez C: Modelling the transmission dynamics of acute haemorrhagic conjunctivitis: application to the 2003 outbreak in Mexico. Stat Med 2006, 25:1840-1857.
42. Lipsitch M, Cohen T, Cooper B, Robins JM, Ma S, James L, Gopalakrishna G, Chew SK, Tan CC, Samore MH, Fisman D, Murray M: Transmission dynamics and control of severe acute respiratory syndrome. Science 2003, 300:1966-1970.
43. Riley S, Fraser C, Donnelly CA, Ghani AC, Abu-Raddad LJ, Hedley AJ, Leung GM, Ho LM, Lam TH, Thach TQ, Chau P, Chan KP, Lo SV, Leung PY, Tsang T, Ho W, Lee KH, Lau EM, Ferguson NM, Anderson RM: Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 2003, 300:1961-1966.
44. Chowell G, Miller MA, Viboud C: Seasonal influenza in the United States, France, and Australia: transmission and prospects for control. Epidemiol Infect 2007, 136:852-864.
45. Viboud C, Tam T, Fleming D, Handel A, Miller MA, Simonsen L: Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine 2006, 24:6701-6707.
46. Andreasen V, Viboud C, Simonsen L: Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies. J Infect Dis 2008, 197:270-278.
47. Chowell G, Ammon CE, Hengartner NW, Hyman JM: Transmission dynamics of the great influenza pandemic of 1918 in Geneva, Switzerland: assessing the effects of hypothetical interventions. J Theor Biol 2006, 241:193-204.
48. Chowell G, Nishiura H, Bettencourt LM: Comparative estimation of the reproduction number for pandemic influenza from daily case notification data. J R Soc Interface 2007, 4:155-166.
49. Mills CE, Robins JM, Lipsitch M: Transmissibility of 1918 pandemic influenza. Nature 2004, 432:904-906.
50. Nishiura H: Time variations in the transmissibility of pandemic influenza in Prussia, Germany, from 1918-19. Theor Biol Med Model 2007, 4:20.
51. Trotter CL, Gay NJ, Edmunds WJ: Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol 2005, 162:89-100.
52. Leroy EM, Baize S, Volchkov VE, Fisher-Hoch SP, Georges-Courbot MC, Lansoud-Soukate J, Capron M, Debré P, McCormick JB, Georges AJ: Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000, 355:2210-2215.
53. Breman JG: The epidemiology of Ebola hemorrhagic fever in Zaire, 1976. Ebola virus haemorrhagic fever. 1978:103-124.
54. Eichner M, Dowell SF, Firese N: Incubation period of ebola hemorrhagic virus subtype zaire. Osong Public Health Res Perspect 2011, 2:3-7.
55. Fine PE: The interval between successive cases of an infectious disease. Am J Epidemiol 2003, 158:1039-1047.
56. Dowell SF, Mukunu R, Ksiazek TG, Khan AS, Rollin PE, Peters CJ: Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 1999, 179:S87-S91.
57. Wallinga J, Lipsitch M: How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci 2007, 274:599-604.
58. Klinkenberg D, Nishiura H: The correlation between infectivity and incubation period of measles, estimated from households with two cases. J Theor Biol 2011, 284:52-60.
59. Hewlett BS, Amola RP: Cultural contexts of Ebola in northern Uganda. Emerg Infect Dis 2003, 9:1242-1248.
60. Chowell G, Fenimore PW, Castillo-Garsow MA, Castillo-Chavez C: SARS outbreaks in Ontario, Hong Kong and Singapore: the role of diagnosis and isolation as a control mechanism. J Theor Biol 2003, 224:1-8.
61. Gumel AB, Ruan S, Day T, Watmough J, Brauer F, van den Driessche P, Gabrielson D, Bowman C, Alexander ME, Ardal S, Wu J, Sahai BM: Modelling strategies for controlling SARS outbreaks. Proc Biol Sci 2004, 271:2223-2232.
62. Breman JG, Johnson KM, van der Groen G, Robbins CB, Szczeniowski MV, Ruti K, Webb PA, Meier F, Heymann DL: A search for Ebola virus in animals in the Democratic Republic of the Congo and Cameroon: ecologic, virologic, and serologic surveys, 1979-1980. Ebola Virus Study Teams. J Infect Dis 1999, 179:S139-S147.
63. Olival KJ, Hayman DT: Filoviruses in bats: current knowledge and future directions. Viruses 2014, 6:1759-1788.
64. Swanepoel R, Smit SB, Rollin PE, Formenty P, Leman PA, Kemp A, Burt FJ, Grobbelaar AA, Croft J, Bausch DG, Zeller H, Leirs H, Braack LE, Libande ML, Zaki S, Nichol ST, Ksiazek TG, Paweska JT, International Scientific and Technical Committee for Marburg Hemorrhagic Fever Control in the Democratic Republic of Congo: Studies of reservoir hosts for Marburg virus. Emerg Infect Dis 2007, 13:1847-1851.
65. Hayman DT, Emmerich P, Yu M, Wang LF, Suu-Ire R, Fooks AR, Cunningham AA, Wood JL: Long-term survival of an urban fruit bat seropositive for Ebola and Lagos bat viruses. PLoS One 2010, 5:e11978.
66. Yuan J, Zhang Y, Li J, Zhang Y, Wang LF, Shi Z: Serological evidence of ebolavirus infection in bats. China. Virol J 2012, 9:236.
67. Lahm SA, Kombila M, Swanepoel R, Barnes RF: Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994-2003. Trans R Soc Trop Med Hyg 2007, 101:64-78.
68. Leroy EM, Epelboin A, Mondonge V, Pourrut X, Gonzalez JP, Muyembe-Tamfum JJ, Formenty P: Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis 2009, 9:723-728.
69. Walsh PD, Abernethy KA, Bermejo M, Beyers R, De Wachter P, Akou ME, Huijbregts B, Mambounga DI, Toham AK, Kilbourn AM, Lahm SA, Latour S, Maisels F, Mbina C, Mihindou Y, Obiang SN, Effa EN, Starkey MP, Telfer P, Thibault M, Tutin CE, White LJ, Wilkie DS: Catastrophic ape decline in western equatorial Africa. Nature 2003, 422:611-614.
70. Jezek Z, Szczeniowski MY, Muyembe-Tamfum JJ, McCormick JB, Heymann DL: Ebola between outbreaks: intensified Ebola hemorrhagic fever surveillance in the Democratic Republic of the Congo, 1981-1985. J Infect Dis 1999, 179:S60-S64.
71. Schoepp RJ, Rossi CA, Khan SH, Goba A, Fair JN: Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg Infect Dis 2014, 20:1176-1182.
72. Pinzon JE, Wilson JM, Tucker CJ, Arthur R, Jahrling PB, Formenty P: Trigger events: enviroclimatic coupling of Ebola hemorrhagic fever outbreaks. Am J Trop Med Hyg 2004, 71:664-674.
73. Ng S, Basta N, Cowling B: Association between temperature, humidity and ebolavirus disease outbreaks in Africa, 1976 to 2014. Euro Surveill 2014, 19. pii: 20892.
74. Doucleff M: Could A 2-Year-Old Boy Be 'Patient Zero' For The Ebola Outbreak? National Public Radio. 25 August 2014, 6:29 PM ET.
75. Chowell G, Nishiura H, Viboud C: Modeling rapidly disseminating infectious disease during mass gatherings. BMC Med 2012, 10:159.
76. Allen L: An Introduction to Stochastic Processes with Applications to Biology. Pearson Education: Upper Saddle River, NJ; 2003.
77. Chan M: Ebola Virus Disease in West Africa -no early end to the outbreak. N Engl J Med 2014, 371:1183-1185.
78. Cohen J: Containing the threat-don't forget Ebola. PLoS Med 2004, 1:e59.
79. Fisher-Hoch SP: Lessons from nosocomial viral haemorrhagic fever outbreaks. Br Med Bull 2005, 73-74:123-137.
80. Borchert M, Mutyaba I, Van Kerkhove MD, Lutwama J, Luwaga H, Bisoborwa G, Turyagaruka J, Pirard P, Ndayimirije N, Roddy P, Van Der Stuyft P: Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned. BMC Infect Dis 2011, 11:357.
81. WHO: Ebola Response Roadmap Update -26 September 2014.
82. Onyango CO, Opoka ML, Ksiazek TG, Formenty P, Ahmed A, Tukei PM, Sang RC, Ofula VO, Konongoi SL, Coldren RL, Grein T, Legros D, Bell M, De Cock KM, Bellini WJ, Towner JS, Nichol ST, Rollin PE: Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004. J Infect Dis 2007, 196:S193-S198.
83. Nkoghe D, Kone ML, Yada A, Leroy E: A limited outbreak of Ebola haemorrhagic fever in Etoumbi, Republic of Congo, 2005. Trans R Soc Trop Med Hyg 2011, 105:466-472.
84. Liberia: Ebola fears rise as clinic is looted. The Washington Post.
85. Phillip A: They survived Ebola. Now they are shunned. The Washington Post.
86. Lamontagne F, Clement C, Fletcher T, Jacob ST, Fischer WA 2nd, Fowler RA, M S Epi: Doing today's work superbly well -treating Ebola with current tools. N Engl J Med, in press.
87. Kucharski AJ, Edmunds WJ: Case fatality rate for Ebola virus disease in West Africa. Lancet 2014. doi:10.1016/S0140-6736(14)61706-2.
88. Chowell G, Castillo-Chavez C, Fenimore PW, Kribs-Zaleta CM, Arriola L, Hyman JM: Model parameters and outbreak control for SARS. Emerg Infect Dis 2004, 10:1258-1263.
89. Lloyd-Smith JO, Galvani AP, Getz WM: Curtailing transmission of severe acute respiratory syndrome within a community and its hospital. Proc Biol Sci 2003, 270:1979-1989.
90. Day T, Park A, Madras N, Gumel A, Wu J: When is quarantine a useful control strategy for emerging infectious diseases? Am J Epidemiol 2006, 163:479-485.
91. Mubayi A, Zaleta CK, Martcheva M, Castillo-Chavez C: A cost-based comparison of quarantine strategies for new emerging diseases. Math Biosci Eng 2010, 7:687-717.
92. Wang W, Ruan S: Simulating the SARS outbreak in Beijing with limited data. J Theor Biol 2004, 227:369-379.
93. Ferguson NM, Cummings DA, Fraser C, Cajka JC, Cooley PC, Burke DS: Strategies for mitigating an influenza pandemic. Nature 2006, 442:448-452.
94. Balcan D, Hu H, Goncalves B, Bajardi P, Poletto C, Ramasco JJ, Paolotti D, Perra N, Tizzoni M, Van den Broeck W, Colizza V, Vespignani A: Seasonal transmission potential and activity peaks of the new influenza A(H1N1): a Monte Carlo likelihood analysis based on human mobility. BMC Med 2009, 7:45.
95. Halloran ME, Ferguson NM, Eubank S, Longini IM Jr, Cummings DA, Lewis B, Xu S, Fraser C, Vullikanti A, Germann TC, Wagener D, Beckman R, Kadau K, Barrett C, Macken CA, Burke DS, Cooley P: Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A 2008, 105:4639-4644.
96. Frieden TR, Damon I, Bell BP, Kenyon T, Nichol S: Ebola 2014 -new challenges, new global response and responsibility. N Engl J Med 2014, 371:1177-1180.
97. Goodman JL: Studying "secret serums" -toward safe, effective Ebola treatments. N Engl J Med 2014, 371:1086-1089.
98. Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP: Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014. doi:10.1038/nature13777.
99. Kroll D: GSK/NIAID Ebola vaccines to enter US, UK human safety trials. Forbes 2014. http://www.forbes.com/sites/davidkroll/2014/08/28/gsk-niaid-ebola-vaccineto-enter-uk-human-safety-trials-broad-international-collaboration/.
100. Outbreak of Ebola hemorrhagic fever, Uganda, August 2000-January 2001. Wkly Epidemiol Record 2001, 76:41-48.